Matkovits Theresa 4
4 · Matinas BioPharma Holdings, Inc. · Filed Oct 16, 2018
Insider Transaction Report
Form 4
Matkovits Theresa
Chief Development Officer
Transactions
- Award
Option (right to buy)
2018-10-15+350,000→ 350,000 totalExercise: $0.79Exp: 2028-10-15→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests as to 25% on October 25, 2019, and the remaining 75% of the shares will vest in equal monthly installments over the following thirty-six (36) months commencing on November 25, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.